ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ANVS Annovis Bio Inc

10.09
0.24 (2.44%)
Apr 19 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Annovis Bio Inc ANVS NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.24 2.44% 10.09 19:59:32
Open Price Low Price High Price Close Price Prev Close
9.85 9.62 10.18 10.06 9.85
more quote information »

Recent News

Date Time Source Heading
4/02/202407:30GLOBEAnnovis Bio Provides Corporate Updates and Reports Fourth..
2/28/202407:08IHMARKETNEWSUS Stock Movers Before Market: Beyond Meat, eBay, First..
2/12/202414:00EDGAR2Form S-3/A - Registration statement under Securities Act of..
2/01/202416:05EDGAR2Form S-3 - Registration statement under Securities Act of..
11/22/202316:27EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
11/21/202314:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/21/202314:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/21/202314:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/21/202314:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202316:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202307:30BWAnnovis Bio Measures Novel Biomarkers in Plasma of..
11/01/202312:28EDGAR2Form 8-K - Current report
11/01/202312:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/31/202308:00BWAnnovis Bio Announces Pricing of $7.5 Million Public..
10/30/202317:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/30/202317:17EDGAR2Form 8-K - Current report
10/30/202316:48BWAnnovis Bio Announces Launch of Proposed Public Offering
10/30/202316:42BWAnnovis Bio Receives Positive Recommendation to Continue..
10/24/202309:13BWAnnovis Bio Showcases Promising Progress in Novel Drug..
9/21/202309:35GLOBEDawson James Securities Announces October Date for 8th..
8/15/202307:20BWAnnovis Bio Announces Second Quarter 2023 Financial Results..
8/14/202316:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/18/202308:18BWContinued Positive Performance of Novel Drug Development by..
6/27/202307:30BWAnnovis Bio Announces the Filing of a Groundbreaking Patent
6/20/202312:05BWAnnovis Bio Receives Excellent Safety Rating and Positive..
6/08/202307:30PRNUSAnnovis Bio Announces Completion of Phase III Parkinson's..

Your Recent History

Delayed Upgrade Clock